Health
Metformin treatment linked to slowed cognitive decline – WebWire
Metformin is the first-line treatment for most cases of type 2 diabetes and one of the most commonly prescribed medications worldwide, with millions of individuals using it to optimise their blood glucose levels. A new research study, conducted over six year…
Metformin is the first-line treatment for most cases of type 2 diabetes and one of the most commonly prescribed medications worldwide, with millions of individuals using it to optimise their blood glucose levels.
A new research study, conducted over six years in the Sydney Memory and Ageing Study in 1037 Australians (aged 70 to 90 years old at baseline), has revealed an additional effect: individuals with type 2 diabetes who used metformin experienced slower cognitive decline with lower dementi…
-
Business18 hours agoAiming for rock-solid retirement income? I’d buy these two ASX shares
-
Noosa News14 hours agoCharlie the therapy dog reduces stress – Proctor
-
Business17 hours agoWarren Buffett says buy this index fund. It could turn $400 per month into $851,800 with help from Apple, Nvidia, and Tesla.
-
General14 hours agoFour charged over alleged six-hour gang rape of girl in south-west Sydney